Cargando…

Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

BACKGROUND: Adenocarcinoma originating from the digestive system is a major contributor to cancer-related deaths worldwide. Tumor recurrence, advanced local growth and metastasis are key factors that frequently prevent these tumors from curative surgical treatment. Preclinical research has demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niess, Hanno, von Einem, Jobst C, Thomas, Michael N, Michl, Marlies, Angele, Martin K, Huss, Ralf, Günther, Christine, Nelson, Peter J, Bruns, Christiane J, Heinemann, Volker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393860/ https://www.ncbi.nlm.nih.gov/pubmed/25879229 http://dx.doi.org/10.1186/s12885-015-1241-x

Ejemplares similares

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial
por: von Einem, Jobst C., et al.
Publicado: (2017)

Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horses
por: Niess, Hanno, et al.
Publicado: (2016)

Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials
por: Stahler, Arndt, et al.
Publicado: (2020)

Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST)
por: Kramer, Klaus, et al.
Publicado: (2015)

Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials
por: Zöhrlaut, Linda Katharina, et al.
Publicado: (2023)

Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
por: Li, Chenghai, et al.
Publicado: (2021)

Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
por: Makhlough, Atieh, et al.
Publicado: (2017)

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration
por: Casiraghi, Federica, et al.
Publicado: (2019)

Mesenchymal Stromal Cell-Based Therapy
por: Mönch, Dina, et al.
Publicado: (2023)

Class I Biocompatible DLP-Printed Acrylate Impairs Adhesion and Proliferation of Human Mesenchymal Stromal Cells in Indirect Cytotoxicity Assay
por: Alt, Franziska, et al.
Publicado: (2023)

Gastrointestinal Mesenchymal Neoplasms other than Gastrointestinal Stromal Tumors: Focusing on Their Molecular Aspects
por: Plesec, Thomas P.
Publicado: (2011)

The Fate of Autologous Endometrial Mesenchymal Stromal Cells After Application in the Healthy Equine Uterus
por: Rink, B. Elisabeth, et al.
Publicado: (2018)

Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306
por: Modest, Dominik Paul, et al.
Publicado: (2020)

Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
por: Reinders, Marlies EJ, et al.
Publicado: (2014)

Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular “pseudoinflammation” contributing to an aggressive phenotype
por: Niess, Hanno, et al.
Publicado: (2014)

Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path
por: Machairiotis, Nikolaos, et al.
Publicado: (2013)

Cancer Stem Cells in Pancreatic Cancer
por: Bao, Qi, et al.
Publicado: (2010)

Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model
por: Fernández-García, María, et al.
Publicado: (2015)

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
por: Trombi, Luisa, et al.
Publicado: (2016)

Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
por: Lamo-Espinosa, José María, et al.
Publicado: (2021)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
por: Stenger, Elizabeth, et al.
Publicado: (2022)

Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012)

Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study
por: Meucci, Maria Chiara, et al.
Publicado: (2021)

Packed Bed Bioreactor for the Isolation and Expansion of Placental-Derived Mesenchymal Stromal Cells
por: Osiecki, Michael J., et al.
Publicado: (2015)

Comparative Efficacy of Autologous Stromal Vascular Fraction and Autologous Adipose-Derived Mesenchymal Stem Cells Combined With Hyaluronic Acid for the Treatment of Sheep Osteoarthritis
por: Lv, Xiaoteng, et al.
Publicado: (2018)

Mesenchymal Stromal Cells “Think” Globally, but Act Locally
por: Eissner, Günther
Publicado: (2023)

Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses
por: Espina, Miguel, et al.
Publicado: (2016)

Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells
por: Zhang, Zijian, et al.
Publicado: (2018)

Ex vivo MRI cell tracking of autologous mesenchymal stromal cells in an ovine osteochondral defect model
por: Markides, Hareklea, et al.
Publicado: (2019)

Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes
por: El-Jawhari, Jehan J, et al.
Publicado: (2021)

Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy
por: Anbazhagan, Murugadas, et al.
Publicado: (2023)

A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome
por: Vivarelli, Marina, et al.
Publicado: (2023)

Autologous angiogenic therapy with cultured mesenchymal stromal cells in platelet-rich plasma for critical limb ischemia
por: Fukuda, Shoji, et al.
Publicado: (2023)

Frequence, Spectrum and Prognostic Impact of Additional Malignancies in Patients With Gastrointestinal Stromal Tumors()()()()
por: Kramer, K., et al.
Publicado: (2015)

Gastrointestinal stromal tumor
por: Stamatakos, Michael, et al.
Publicado: (2009)

Gastrointestinal stromal tumors
por: Beham, Alexander W., et al.
Publicado: (2011)

Application of autologous endometrial mesenchymal stromal/stem cells increases thin endometrium receptivity: a case report
por: Sapozhak, I. M., et al.
Publicado: (2020)

Implantation of Autologous Expanded Mesenchymal Stromal Cells in Hip Osteonecrosis through Percutaneous Forage: Evaluation of the Operative Technique
por: Gómez-Barrena, Enrique, et al.
Publicado: (2021)

Technology for Repairing Osteomyelitic Bone Defects Using Autologous Mesenchymal Stromal Cells on a Collagen Matrix in Experiment
por: Mitrofanov, V.N., et al.
Publicado: (2021)

Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients
por: Lee, Joonyub, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7isbc39lsdc0anqo0k997meu4o